Enzalutamide is a nonsteroidal antiandrogen used to treat metastatic castration-resistant prostate cancer.
EUDMF & USDMF are available.
All Products protected by valid patents are for laboratory analytical/research purposes only and are not offered for sale in countries or area where the sale of such products constitutes a patent infringement, its liability is at buyer's risk!
Enzalutamide is a potent non-steroidal androgen receptor inhibitor used in oncology. Its core synthesis involves complex organic coupling reactions. The molecular formula is C24H26F3N5O2 with CAS No. 1049257-56-8.
Strictly contraindicated in pregnancy due to fetal harm. Store under controlled room temperature (20°C to 25°C) in original sealed containers to prevent degradation. Handle with PPE to avoid inhalation or skin contact during processing.